POLECAT: Perioperative Delta Renin Concentration (POLECAT)

We want to measure the amount of a hormone called renin in people's bodies before and after they have major abdominal surgery. We want to see if changes in renin levels are connected to problems with blood flow, unstable blood pressure, and kidney damage after surgery.

Study Overview

Status

Not yet recruiting

Detailed Description

The renin-angiotensin system (RAS) plays a key role in haemodynamic stability, vascular tone and electrolyte homeostasis. It is recognised that this system is dysfunctional during critical illness. It remains unknown as to whether significant dysfunction of RAS is found in patients who have undergone major abdominal surgery - however over 50% of these patients often require blood pressure support post-operatively, with nearly half of these patients having unexplained drops in blood pressure.

Renin represents an attractive biomarker that could be implicated in post operative vasoplegia and post operative AKI and as such elevated renin concentrations could be used to identify high-risk patients for cardiovascular instability and AKI who would benefit from timely intervention that could improve their outcomes, this would include the use of selective vasopressor agents such as angiotensin II which has been shown to confer a benefit in patients with underlying dysregulation of the RAS.

If we show that higher differences in renin concentrations are associated with a greater incidence of vasoplegia then we can design a subsequent clinical trial with a different treatment in those who have a higher change in renin. Such a trial is currently recruiting in Germany for patients with higher changes in renin due to cardiac surgery.

The primary aim is to assess whether there is an association between higher differences in renin concentrations (a protein that can be measured in your blood) and haemodynamic instability manifest as vasoplegia (patients exhibiting low blood pressure) in patients undergoing major abdominal surgery requiring post-operative admission to ICU.

Study Type

Observational

Enrollment (Estimated)

405

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Planned and unplanned emergency general surgical procedures. All surgical patients who have an intensive care bed booked, will be screened.

To sample patients we will approach all patients who are booked to come to the ICU post operatively.

Description

Inclusion Criteria:

  • Age ≥18 years
  • All patients having abdominopelvic surgery (planned or unplanned) needing ICU admission where arterial line or central line will been placed
  • Able to provide consent, or personal/professional agreement

Exclusion Criteria:

  • Patient < 18 years old at time of screening
  • Patients already receiving vasopressor support pre-operatively
  • Receiving palliative care at the time of recruitment or expected to die within next 24 hours
  • Those on kidney replacement therapy (KRT) or end stage kidney disease (ESKD)
  • Patient or consultee unable to communicate in verbal and written English
  • Patients held in an institution by legal or official order
  • Patients with severe mental health disorders that might impair their capacity

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
• The difference between pre and post-operative levels of circulating renin, and association with vasoplegia.
Time Frame: 2 years
2 years

Secondary Outcome Measures

Outcome Measure
Time Frame
• Determine overall burden of vasopressor use post operatively.
Time Frame: 2 years
2 years
• Incidence of post-operative AKI in this cohort of patients
Time Frame: 2 years
2 years
• Trends of renin post-operatively following major abdominal surgery.
Time Frame: 2 years
2 years
• Associations between changes in renin and AKI.
Time Frame: 2 years
2 years
• Associations between type of surgery and incidence of post operative instability and renin measurements, with specific emphasis on patients with emergency surgery with peritonitis.
Time Frame: 2 years
2 years
• Association between regular medications that alter the RAS-axis and changes in renin
Time Frame: 2 years
2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Lui Forni, Professor of Intensive Care Medicine, Royal Surrey Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

July 1, 2023

Primary Completion (Estimated)

July 1, 2025

Study Completion (Estimated)

July 1, 2025

Study Registration Dates

First Submitted

July 4, 2023

First Submitted That Met QC Criteria

July 4, 2023

First Posted (Actual)

July 12, 2023

Study Record Updates

Last Update Posted (Actual)

July 12, 2023

Last Update Submitted That Met QC Criteria

July 4, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Kidney Injury

Subscribe